NCT00051766

Brief Summary

The purpose of this study is to evaluate the effectiveness of a computer-assisted, self-administered adherence program for patients on complicated anti-HIV drug regimens.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 17, 2003

Completed
Last Updated

June 24, 2005

Status Verified

May 1, 2005

First QC Date

January 16, 2003

Last Update Submit

June 23, 2005

Conditions

Keywords

compliancemedicationantiretroviraladherenceinterventiontreatment experienced

Interventions

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Receiving HIV care at San Francisco General Hospital's Positive Health Program
  • Three or more antiretroviral medications
  • HIV-1 viral load \> 500 copies/ml
  • At least one previous salvage regimen
  • Ability to read English at 8th grade level

You may not qualify if:

  • Visual impairments that prevent patient from reading text on a computer screen
  • Obvious cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Francisco General Hospital

San Francisco, California, 94110, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV InfectionsPatient Compliance

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Frederick M. Hecht, MD

    San Francisco General Hospital

    STUDY CHAIR
  • Amy B. Bronstone, PhD

    West Portal Software Corporation

    STUDY DIRECTOR
  • Roger Hofmann, BS

    West Portal Software Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
ECT
Intervention Model
FACTORIAL
Sponsor Type
NIH

Study Record Dates

First Submitted

January 16, 2003

First Posted

January 17, 2003

Last Updated

June 24, 2005

Record last verified: 2005-05

Locations